About us
About us
About
About
Impact through deep domain expertise.
Impact through deep domain expertise.
Our mission
Sphere is a commercialization partner for medtech and healthcare deep tech.
We sit where evidence, business development and digital execution meet, turning strong technologies into credible, investable and adoptable offerings.
We focus on a narrow set of things and do them in depth: business development, commercialization workshops, operational marketing, and web & brand. Together, they form one system around your assets, a clear growth thesis, a disciplined BD pipeline, and a digital presence that makes your solution easy to find, easy to trust, and easy to act on.
Sphere is founded by the founder of SUAZIO, the medtech and IVD strategic consultancy acquired by NAMSA, a leading global MedTech CRO, in 2023.
That heritage brings two decades of global market research and commercialization experience, thousands of projects across devices, diagnostics and digital health, into our work with founders and investors.
Our team combines that research backbone with hands-on BD, marketing and product work in hospital networks, cybersecurity and workflow platforms. The result: commercial thinking that matches the discipline of your clinical and technical work, and a partner that understands how real adoption happens in regulated healthcare systems
Sphere is a commercialization partner for medtech and healthcare deep tech.
We sit where evidence, business development and digital execution meet, turning strong technologies into credible, investable and adoptable offerings.
We focus on a narrow set of things and do them in depth: business development, commercialization workshops, operational marketing, and web & brand. Together, they form one system around your assets, a clear growth thesis, a disciplined BD pipeline, and a digital presence that makes your solution easy to find, easy to trust, and easy to act on.
Sphere is founded by the founder of SUAZIO, the medtech and IVD strategic consultancy acquired by NAMSA, a leading global MedTech CRO, in 2023.
That heritage brings two decades of global market research and commercialization experience, thousands of projects across devices, diagnostics and digital health, into our work with founders and investors.
Our team combines that research backbone with hands-on BD, marketing and product work in hospital networks, cybersecurity and workflow platforms. The result: commercial thinking that matches the discipline of your clinical and technical work, and a partner that understands how real adoption happens in regulated healthcare systems
Team
Team
Meet the team
Meet the team
A compact senior bench combining medtech insight, BD discipline and digital execution to move evidence-based technologies faster from validation to adoption.
A compact senior bench combining medtech insight, BD discipline and digital execution to move evidence-based technologies faster from validation to adoption.
Career
We're hiring.
We grow slowly and selectively. If you bring medtech or deep-tech-in-health experience and can move the needle on BD, commercialization or digital execution, we’re open to a conversation.
Strategic partnership
Strategic partnership
Meet our partners
Meet our partners
Jarlen Capital focuses on connecting emerging biotechs, big pharma and private equity across borders, adding global BD&L and capital reach to our work.
Jarlen Capital focuses on connecting emerging biotechs, big pharma and private equity across borders, adding global BD&L and capital reach to our work.
FAQ
Frequently asked questions
Who is this for?
Medtech ventures and investors who need a structured, partner-oriented commercial engine rather than ad-hoc outreach or isolated pilots.
What outcomes can we expect?
How do you work with our existing BD or sales team?
What do you need from us to start?
How quickly do we see movement?
Who is this for?
Medtech ventures and investors who need a structured, partner-oriented commercial engine rather than ad-hoc outreach or isolated pilots.